Publication Ethics & Malpractice Statement

PhytoTalks is committed to maintaining the highest standards of publication ethics, editorial integrity, and transparency in all stages of manuscript submission, peer review, editorial decision-making, and publication.

The journal follows internationally accepted ethical guidelines and best practices in scholarly publishing, including the principles of the Committee on Publication Ethics (COPE), recommendations of the International Committee of Medical Journal Editors (ICMJE), and accepted norms for academic integrity.

All authors, editors, reviewers, and publisher representatives are expected to adhere to the ethical responsibilities outlined below.

1. Duties and Responsibilities of Authors

1.1 Originality and Plagiarism

Authors must ensure that their submitted manuscripts are original works and have not been copied, plagiarized, or inappropriately paraphrased from other published or unpublished sources.

  • Proper acknowledgment of the work and ideas of others must always be provided.
  • All submissions may be checked using plagiarism detection software.
  • Manuscripts found to contain plagiarism, excessive similarity, or unattributed content may be rejected immediately or retracted after publication, if necessary.

1.2 Multiple, Redundant, or Concurrent Submission

Authors must not submit the same manuscript simultaneously to more than one journal or publisher.

  • Submitting the same work to multiple journals at the same time constitutes unethical publishing behavior.
  • Manuscripts that substantially overlap with previously published work must clearly cite and justify the overlap.

1.3 Data Accuracy and Integrity

Authors are responsible for the accuracy, authenticity, and integrity of all data presented in their manuscripts.

  • Data should be represented honestly and without fabrication, falsification, manipulation, or inappropriate image enhancement.
  • Authors may be asked to provide raw data, supporting files, ethical approvals, or supplementary evidence for editorial review.
  • Fraudulent or knowingly inaccurate statements are considered unethical and unacceptable.

1.4 Authorship and Contribution

Authorship should be limited to individuals who have made a significant intellectual contribution to the work, including one or more of the following:

  • conception or design of the study;
  • data collection, analysis, or interpretation;
  • drafting or critically revising the manuscript;
  • approval of the final version for publication.

All listed authors must:

  • approve the final manuscript before submission;
  • agree to its submission and publication;
  • accept responsibility for the content of the work.

Individuals who contributed to the work but do not meet authorship criteria should be acknowledged appropriately.

The following practices are considered unethical:

  • Ghost authorship
  • Gift authorship
  • Guest authorship
  • omission of deserving contributors

1.5 Use of Artificial Intelligence (AI) Tools

If authors use AI-assisted tools (such as language editing, grammar assistance, or content generation tools), such use must be transparent and responsibly disclosed where relevant.

Authors remain fully responsible for:

  • the originality of the manuscript,
  • the factual accuracy of all content,
  • proper citation of sources,
  • and the scientific integrity of the submission.

AI tools must not be listed as authors.

1.6 Acknowledgment of Sources

Authors must properly cite all sources, references, datasets, software, images, figures, and previously published material used in the manuscript.

Failure to provide proper acknowledgment may constitute ethical misconduct.

1.7 Disclosure of Conflicts of Interest

Authors must disclose any financial, institutional, personal, academic, or other relationships that could influence the interpretation of their work.

Examples include:

  • funding or sponsorship,
  • employment,
  • consultancy,
  • stock ownership,
  • patent applications,
  • personal or professional rivalries.

A Conflict of Interest statement must be included in the manuscript where applicable.

1.8 Funding Disclosure

Authors must clearly disclose all sources of funding or financial support for the research and publication.

If no external funding was received, authors should state:

“The authors received no specific funding for this work.”

1.9 Ethical Approval and Research Compliance

Where applicable, authors must confirm that the research was conducted in accordance with relevant institutional, national, and international ethical standards.

If the research involves:

  • human participants,
  • animal subjects,
  • field studies,
  • protected species,
  • hazardous materials,
  • or sensitive biological resources,

authors must provide appropriate ethical approval details, permissions, and compliance statements.

1.10 Corrections of Errors

If an author discovers a significant error or inaccuracy in a published paper, the author is obligated to promptly notify the journal editor and cooperate in correcting or retracting the article where necessary.

2. Duties and Responsibilities of Reviewers

Peer reviewers play an essential role in maintaining the scholarly quality and integrity of the journal.

2.1 Confidentiality

Manuscripts received for review must be treated as confidential documents.

Reviewers must not:

  • share, distribute, or discuss the manuscript with others without editorial permission;
  • use unpublished material disclosed in the manuscript for personal research or advantage.

2.2 Objectivity and Constructive Feedback

Reviews should be conducted objectively, fairly, and professionally.

Reviewers should provide:

  • clear,
  • evidence-based,
  • constructive,
  • and respectful comments

that help editors make decisions and authors improve their manuscripts.

Personal criticism of the author is inappropriate.

2.3 Competence and Timeliness

Reviewers should accept review assignments only if they have the necessary expertise and are able to complete the review within the requested time.

If a reviewer feels unqualified or unable to review on time, they should promptly inform the editor.

2.4 Identification of Ethical Concerns

Reviewers should notify the editor if they identify possible ethical concerns, including:

  • plagiarism,
  • duplicate publication,
  • data fabrication or falsification,
  • unethical research practices,
  • citation manipulation,
  • or significant overlap with other published work.

2.5 Conflict of Interest

Reviewers must decline to review manuscripts in which they have any conflict of interest, including:

  • personal relationships,
  • academic competition,
  • collaborative connections,
  • institutional association,
  • financial interest.

Reviewers must not use information obtained during peer review for personal gain.

3. Duties and Responsibilities of Editors

Editors are responsible for ensuring the quality, fairness, transparency, and integrity of the journal’s editorial process.

3.1 Fair and Unbiased Editorial Decisions

Editors evaluate manuscripts based on their:

  • originality,
  • scientific merit,
  • clarity,
  • relevance to the journal’s scope,
  • methodological soundness,
  • and contribution to knowledge.

Editorial decisions must not be influenced by:

  • race,
  • gender,
  • religion,
  • nationality,
  • institutional affiliation,
  • political beliefs,
  • or personal relationships.

3.2 Confidentiality

Editors and editorial staff must not disclose any information about submitted manuscripts to anyone other than the corresponding author, reviewers, editorial advisors, and publisher as appropriate.

3.3 Peer Review Integrity

Editors are responsible for ensuring that manuscripts undergo a fair, objective, and confidential peer review process.

Editors should:

  • select suitably qualified reviewers,
  • avoid conflicts of interest,
  • monitor review quality,
  • and take appropriate action if unethical review behavior is suspected.

3.4 Conflicts of Interest

Editors must recuse themselves from handling manuscripts in which they have conflicts of interest due to:

  • personal relationships,
  • institutional connections,
  • academic collaboration,
  • financial interests,
  • or competitive circumstances.

In such cases, editorial responsibility should be reassigned.

3.5 Ethical Oversight

Editors will take reasonable steps to identify and prevent the publication of papers involving misconduct, including:

  • plagiarism,
  • fabricated or falsified data,
  • manipulated citations,
  • duplicate publication,
  • unethical experimentation,
  • or authorship disputes.

No editor shall encourage or knowingly allow such misconduct.

3.6 Handling Complaints and Appeals

Editors will consider:

  • author appeals,
  • reviewer concerns,
  • ethical complaints,
  • and requests for correction

in a fair and timely manner.

Where necessary, the journal may consult the guidance of COPE or institutional authorities.

4. Duties and Responsibilities of the Publisher

The publisher of PhytoTalks is committed to supporting editorial independence and maintaining ethical publishing standards.

The publisher shall:

  • support editors in handling ethical issues and allegations of misconduct;
  • ensure that commercial or financial considerations do not compromise editorial decisions;
  • preserve the integrity of the academic record;
  • assist in issuing corrections, clarifications, retractions, or removals where required.

5. Peer Review Policy

All manuscripts submitted to PhytoTalks are subject to an editorial screening followed by peer review before acceptance for publication.

The peer review process is intended to assess:

  • originality,
  • relevance,
  • scientific quality,
  • methodological rigor,
  • clarity of presentation,
  • and ethical compliance.

The editorial office reserves the right to reject manuscripts at the preliminary stage if they are outside the journal scope, ethically problematic, or scientifically unsuitable.

6. Publication Misconduct

The journal takes all forms of publication misconduct seriously.

Examples of misconduct include, but are not limited to:

  • plagiarism,
  • self-plagiarism,
  • duplicate publication,
  • data fabrication,
  • data falsification,
  • manipulated images,
  • false authorship claims,
  • citation manipulation,
  • peer review manipulation,
  • undisclosed conflicts of interest,
  • unethical research conduct.

If misconduct is suspected before or after publication, the journal may initiate an investigation.

7. Complaints, Allegations, and Investigations

Any allegation of ethical misconduct or malpractice will be handled seriously, fairly, and confidentially.

The journal may investigate concerns related to:

  • authorship disputes,
  • plagiarism,
  • data concerns,
  • peer review misconduct,
  • editorial bias,
  • publication malpractice,
  • ethical approval issues.

Investigations may involve:

  • communication with authors, reviewers, and editors;
  • requests for explanations or supporting documents;
  • consultation with institutions, ethics committees, or relevant authorities;
  • reference to COPE flowcharts and ethical guidance.

The journal will provide the concerned parties an opportunity to respond before any final action is taken.

8. Corrections, Retractions, and Editorial Expressions of Concern

To preserve the integrity of the scholarly record, PhytoTalks may publish:

8.1 Corrections

A correction may be issued when a published article contains an error that affects clarity, accuracy, indexing, or interpretation but does not invalidate the overall findings.

8.2 Retractions

An article may be retracted if there is clear evidence of:

  • unreliable findings,
  • plagiarism,
  • duplicate publication,
  • unethical research,
  • fabricated or falsified data,
  • serious authorship or integrity violations.

Retraction notices will remain permanently linked to the original article.

8.3 Expressions of Concern

Where a serious concern exists but conclusive evidence is still pending, the journal may issue an Editorial Expression of Concern.

9. Conflicts of Interest Policy

All participants in the publication process — including authors, reviewers, editors, and editorial board members — must disclose any conflicts of interest that could affect the objectivity or integrity of the editorial process.

Failure to disclose a relevant conflict of interest may lead to rejection, correction, or retraction, depending on the severity of the case.

10. Copyright, Licensing, and Ethical Use of Published Content

Authors publishing in PhytoTalks are expected to ensure that all submitted material complies with copyright and permission requirements.

Authors must obtain permission where required for:

  • reproduced figures,
  • tables,
  • illustrations,
  • lengthy quotations,
  • copyrighted content from third parties.

Unauthorized use of copyrighted material may result in rejection or removal of the manuscript.

11. Archiving and Integrity of the Scholarly Record

The journal is committed to preserving published content and maintaining the reliability of the academic record.

Published articles shall remain part of the permanent scholarly archive unless legal, ethical, or exceptional circumstances require formal correction, retraction, or removal.

12. Ethical Compliance and Policy Updates

This Publication Ethics and Malpractice Statement may be updated periodically to reflect evolving ethical standards and best practices in scholarly publishing.

Authors, reviewers, editors, and readers are encouraged to consult the latest version of this policy on the journal website.

PhytoTalks is committed to ethical publishing and follows internationally recognized standards of editorial and publication ethics.